SPECIAL BLACK FRIDAY PROMOTION CALL 1-833-477-4376 :
PROMO CODE "BLACK007"
We offer the first of its kind, in-home sexual dysfunction device. It is FDA cleared Class II medical device. While the device is the first for the sexual dysfunction market, similar devices are commonly used by other medical specialties. The device utilizes a proven technology called Low Intensity Pulsed Ultrasound (LIPUS) which is the application of acoustic waves to increase blood flow. The treatment can be done at home. The device works on both men and women.
The device produces acoustic waves which result in vascular regeneration and increased blood flow in the clitoris. It specifically uses Low-Intensity Pulse Ultrasound (LIPUS) technology.
You can use the device with other medications but please consult with a Physician if you have any medical questions. If you are taking oral sexual dysfunction medications or supplements, prescribed by your Physician, you can continue taking them as long as prescribed and as long as you feel necessary. It also works with stem cell treatments, “P” Shot and “O” Shot protocols.
There are numerous white papers, and clinical research available, to substantiate the efficacy of acoustic waves in the treatment of sexual dysfunction. Acoustic wave therapy has been shown to be successful for 70% of the people who used it. The penis and the clitoris have the same tissue and therefore the device works equally well on men and women. We have seen a 90%+ success rate with our customers due to presale screening and post-sale training.
Whether the VascuWave™ device is used in conjunction with in-clinic treatments or on its own, the cost is low compared to alternative treatments. The device was developed in the USA and comes with a full 2-year warranty provided as part of the purchase price. Further, you receive a 180-day 100% full money-back guarantee. Additionally, and most importantly, medical professionals are involved and available to help you throughout your journey to sexual wellness. Just like many devices there are “knockoff” products available. However, they don’t have the warranties, guarantees, protocols or support that VascuWave™ has. It is time to use the latest in medical technology and our proprietary protocols developed by our Medical Doctors to treat sexual dysfunction.
Yes. We offer full telephone, chat and email support between 9am and 5pm PST, Monday to Friday. If you call after these hours a “live-operator” will take your message and we’ll call you back the next business day. You can also email or “chat” with us at VascuWave.com. Once you purchase the device you will be assigned a dedicated Patient Support Specialist who will help you with future use questions via phone, “live chat” or email. If you were issued the device as part of a treatment program from a Physician you will also receive support from him or her.
Just as a Physician cannot guarantee you perfect health and we can’t guarantee the device will work for everyone. We know it works for the vast majority of people who use the device and we want you to be one of them. Remember, we offer a full 180-day 100% money-back-guarantee so you can return it if it doesn’t work for you. There is also a 2-year warranty provided as part of the purchase price.
The device should be moved slowly along the treatment area. Patients can use the device two, three, four or five times a week. Based on preference or medical advice, patients can use the device up to five times a week. Each session is a 30-minute application for six weeks, constitutes the initial protocol cycle. Maintenance cycles, consisting of two thirty-minute applications per week, should be undertaken every six months.
Detailed instructions on the use of the device are included with the device manual. VascuWave™ is used by applying the wave generating wand head to the clitoris for women (or penis for men) and surrounding areas. The device should be moved slowly along the treatment area. Patients can use the device two, three, four or five times a week. Each session is a 30-minute application per week, for six weeks, constitutes the initial protocol cycle. Maintenance cycles, consisting of two thirty-minute applications per week, should be undertaken every six months.
The VascuWave™ Home Device, and competitors like GainsWave and Swisswave, use acoustic wave technology to apply treatments. VascuWave™ utilities LIPUS for its protocols while the others use ESWT. The biologic effects of therapeutic ultrasound LIPUS (VascuWave™) and shock wave therapy (ESWT - GainsWave™), namely microtrauma and neovascularization, are indistinguishable with the propriety protocols VascuWave™ uses for the clitoris. We know of no clinical information that indicates that ESWT works on the clitoris.
There are numerous papers, and clinical research available, to substantiate the efficacy of acoustic waves in the treatment of ED (Sexual Dysfunction). Acoustic waves in the treatment of Sexual Dysfunction, Low-Intensity Pulsed Ultrasound (LIPUS) has been shown to be successful for 70% of the women who used it. However, our customer satisfaction levels far exceed that percentage. You should not anticipate seeing the benefits of the device until completion of the initial application cycle.
The use of the device is painless, non-invasive and has no side effects.
We do not accept insurance for the device at this time as sexual dysfunction is a condition not usually covered.
Michael J. Dattoli, MD, is a board-certified radiation oncologist with well over two decades of brachytherapy experience and has performed thousands of prostate implant procedures. He is considered the foremost pioneer optimizing brachytherapy designs to maximize tumor eradication and minimize symptoms. He is a noted author and speaker in this complex field of medicine. Dr. Dattoli attended the University of California at Berkeley and was the Valedictorian of his class at Vassar College; he earned his medical degree at Mount Sinai School of Medicine, Radiation Oncology at New York University Medical Center, then distinguished himself at Memorial Sloan-Kettering Cancer Center and New York Hospital-Cornell University Medical Center, as the Special Fellow in Brachytherapy. Dr. Dattoli serves on multiple journal editorial review boards. Government appointments include “The Prostate Cancer Task Force” in Florida and consultant to the “Washington Oncology Roundtable Advisory Committee”. He was selected by the International Association of Oncologists as a Leading Physician of the World and top Brachytherapist.
Joseph M. Kaminski, MD, previously Senior Medical Staff at the National Cancer Institute at the National Institutes of Health, is a board-certified Radiation Oncologist who is internationally known for his work in accelerating the development of cancer therapeutics including normal tissue radioprotectors/mitigators, imaging techniques, and important interventional devices. He has authored more than 70 publications in peer reviewed journals and has served on multiple journal editorial boards. Dr. Kaminski has also held positions as a Lead Medical Officer at the Food and Drug Administration. He was also a medical officer at the National Institutes of Allergy and Infectious Diseases. He graduated with highest honors from Georgia Institute of Technology, one of the nation’s top bioengineering universities, and completed medical school at the Medical College of Georgia.
Dr. Stanislav Emelianov is a Joseph M. Pettit Endowed Chair, Georgia Research Alliance Eminent Scholar, and Professor of Electrical & Computer Engineering and Biomedical Engineering at the Georgia Institute of Technology. He is also appointed at Emory University School of Medicine where he is Professor of Radiology and is affiliated with Emory’s Winship Cancer Institute and other clinical units. Dr. Emelianov is an internationally recognized expert in biomedical imaging instrumentation and nanoagents for imaging and therapy. He is the author of over 500 publications including peer-reviewed research articles, invited reviews, book chapters, conference proceedings, and patents. In recognition of his contributions to the field, Dr. Emelianov was elected to the College of Fellows of the American Institute for Medical and Biological Engineering. He is past Vice-President for Ultrasonics of the IEEE Ultrasonics, Ferroelectrics and Frequency Control Society, and senior member of several professional organizations.
Dr. Mechanick is Professor of Medicine and Medical Director of the Marie-Josee and Henry R.Kravis Center for Cardiovascular Health at Mount Sinai Heart, and in the Cardiovascular Institute and Division of Cardiology, and Director of Metabolic Support in the Division of Endocrinology, Diabetes and Bone Disease, Icahn School of Medicine at Mount Sinai. He received his M.D. degree from the Icahn School of Medicine at Mount Sina. Dr. Mechanick authored over 300 publications in Endocrinology, Metabolism, and Nutrition Support. Dr. Mechanick co-edited Nutritional Strategies for theDiabetic and Prediabetic Patient, Power of Prevention: The Complete Guide to Lifelong Nutrition, Thyroid Cancer: From Emergent Biotechnology to Clinical Practice Guidelines, Molecular Nutrition. Dr. Mechanick was appointed as a member of the President’s Council on Fitness, Sports and Nutrition (PCFSN) and Science Board for 2010-2013. Dr. Mechanick also chairs the International Transcultural Diabetes Nutrition Algorithm Working Group.
Orhan H. Suleiman, MS, PhD, FAAPM, FHPS, has expertise encompassing a broad range of scientific and regulatory experience related to Food and Drug Administration (FDA) regulated medical products (drugs, medical devices, and biologics). He retired in November, 2014, from the United States FDA, after 37 years with the federal agency responsible for assuring the safety and efficacy of such products. At FDA he was the Senior Science Policy Advisor in the Office of New Drugs, where he was involved in many regulatory initiatives involving safety, human subject research, and inspections. He represented the FDA on a variety of domestic and international committees. He received his BS (1970) and MS (1972) degrees in Radiological Sciences from the University of Florida, and his Ph.D. (1989) from the Johns Hopkins School of Hygiene and Public Health. In 1998 he was appointed into FDA’s Senior Biomedical Research Service (SBRS), a select group of federal senior level scientists. In 1999 he was elected as a Fellow of the American Association of Physicists in Medicine (AAPM), served as president of the Baltimore Washington Chapter of the Health Physics Society (2006-7), and in 2013 he was also selected as a Fellow in the Health Physics Society. He is an Emeritus member of these societies as well as the Society of Nuclear Medicine and Molecular Imaging (SNMMI). He has authored over 50 formal publications in the scientific literature, and presented numerous times domestically and internationally on these topics.
Jeffrey K. Russell has more than thirty years of international business leadership experience with focus on multi-location business revenue generation in the healthcare and government sectors. Specifically, he has expertise developing rapid growth strategies for start-up organizations, expanding global markets and building sustainable success.As a pioneer in global Business Process Outsourcing (BPO) management, Mr. Russell has lived and worked in North America, Europe, the Middle East and Southeast Asia.Throughout the years, Mr. Russell has consulted with or directed customer acquisition and customer retention operations involving the U.S. Department of Justice, Microsoft, Readers Digest, Dunn & Bradstreet, Global Healthcare Communications, Universal Savings Bank, Newsweek, Nokia, DHL, Tiger Direct, Microsoft, the Malaysian Ministry of Education and The Malaysian Federation of Manufacturers.Upon return to the U.S., Mr. Russell led franchisee operations related to direct access medical lab testing. He has also participated in developing next generation technology solutions for wellness clinics and medical spas with specific focus on acoustic wave and shock wave therapy. He also worked with the U.S. Department of Justice building contact center training and operational capabilities inside female federal prisons.As VascuWave CEO, Mr. Russell leads the effort to grow the organization and related brands globally. He is a U.S. Air Force Veteran.
What Have You got to Lose - START THE PROCESS NOW
We are, so confident about VascuWave, we offer 100% money back guarantee for 180 days.
Money Back Guarantee
180 day money back guarantee,
if not 100% satisfied
2 year warranty against any manufacturing defects
Free discrete shipping
within US 48 states